nach oben

Clinical Rheumatology

Erschienen in:

19.12.2019 | Original Article

Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis

verfasst von: Xue Li, Zhenni Wang, Han Yi, Jun Xie, Naishuo Zhu

Erschienen in: Clinical Rheumatology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Anticitrullinated protein/peptide antibodies (ACPAs) have shown valuable effects in the diagnosis of rheumatoid arthritis (RA). Both fibrinogen and vimentin are significant antigens of ACPAs. This study evaluated the diagnostic performance of fibrinogen and vimentin peptides in RA.

Methods

We searched the PubMed, Embase, and Cochrane Library databases for studies published in English until January 2019 that evaluated the utility of the peptides of both vimentin and fibrinogen. The bivariate mixed-effects model and summary receiver operating characteristic (SROC) curve were used to estimate sensitivity and specificity across studies.

Results

Seven peptides from 19 studies were included. The pooled sensitivities of Fibα36–50, Fibα563–583, Fibα580–600, Fibα621–635, Fibβ36–52, Fibβ60–74, and Vim60–75 were 35%, 41%, 18%, 26%, 0.53%, 57%, and 44%, respectively. The pooled specificities of Fibα36–50, Fibα563–583, Fibα580–600, Fibα621–635, Fibβ36–52, Fibβ60–74, and Vim60–75 were 97%, 98%, 98%, 98%, 97%, 98%, and 98%, respectively. The SROC areas under the curve (AUCs) of Fibα36–50, Fibα563–583, Fibα580–600, Fibα621–635, Fibβ36–52, Fibβ60–74, and Vim60–75 were 0.92, 0.85, 0.64, 0.82, 0.91, 0.96, and 0.86, respectively.

Conclusion

Both fibrinogen and vimentin peptides have a high specificity but a relatively low sensitivity in diagnosing RA. The diagnostic accuracies of Fibβ60–74 and Fibβ36–52 were better than those of Vim60–75, Fibα36–50, and Fibα563–583, and all of them were better than that of Fibα621–635 and Fibα580–600.

Key Points

• Our study summarized the diagnostic accuracy of peptides derived from fibrinogen and vimentin and evaluated the diagnostic value of different peptides for RA patients.

• Both fibrinogen and vimentin peptides have a high specificity but a relatively low sensitivity in diagnosing RA.

Nur mit Berechtigung zugänglich

Gavrila BI, Ciofu C, Stoica V (2016) Biomarkers in rheumatoid arthritis, what is new? J Med Life 9(2):144–148PubMedPubMedCentral

Shi J, Knevel R, Suwannalai P et al (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage[J]. Proc Natl Acad Sci U S A 108(42):17372–17377PubMedPubMedCentral

Trouw LA, Mahler M (2012) Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev 12(2):318–322PubMed

Badillo-Soto MA, Rodriguez-Rodriguez M, Perez-Perez ME et al (2016) Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning. Eur J Rheumatol 3(2):44–49PubMedPubMedCentral

Trier NH, Holm BE, Slot O et al (2016) Physical characteristics of a citrullinated pro-filaggrin epitope recognized by anti-citrullinated protein antibodies in rheumatoid arthritis sera. PLoS One 11(12):e168542

Takizawa Y, Suzuki A, Sawada T et al (2006) Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 65(8):1013–1020PubMedPubMedCentral

Malakoutikhah M, Gomara MJ, Gomez-Puerta JA et al (2011) The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis. J Med Chem 54(21):7486–7492PubMed

Reed E, Jiang X, Kharlamova N et al (2016) Antibodies to carbamylated alpha-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies. Arthritis Res Ther 18(1):96PubMedPubMedCentral

Koivula MK, Heliovaara M, Rissanen H et al (2012) Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Ann Rheum Dis 71(10):1666–1670PubMed

10.

Vander CB, Cantaert T, Nogueira L et al (2006) Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther 8(4):R122

11.

Bang H, Egerer K, Gauliard A et al (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56(8):2503–2511PubMed

12.

Luime JJ, Colin EM, Hazes JM, Lubberts E (2010) Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis 69(2):337–344PubMed

13.

Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341PubMed

14.

Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMed

15.

Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581PubMed

16.

Whiting P, Rutjes AW, Reitsma JB et al (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25PubMedPubMedCentral

17.

Cheung MW, Vijayakumar R (2016) A guide to conducting a meta-analysis. Neuropsychol Rev 26(2):121–128PubMed

18.

McKenzie JE, Beller EM, Forbes AB (2016) Introduction to systematic reviews and meta-analysis. Respirology 21(4):626–637PubMed

19.

Jonsson MK, Hensvold AH, Hansson M et al (2018) The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy. Arthritis Res Ther:20(1)

20.

Cornillet M, Babos F, Magyar A et al (2018) Seropositivity and antibody profiling of patients are dramatically impacted by the features of peptides used as immunosorbents: a lesson from anti-citrullinated protein/peptide antibody. J Immunol 201(11):3211–3217PubMed

21.

Too CL, Murad S, Hansson M et al (2017) Differences in the spectrum of anti-citrullinated protein antibody fine specificities between Malaysian and Swedish patients with rheumatoid arthritis: implications for disease pathogenesis. Arthritis Rheum 69(1):58–69

22.

Cornillet M, Ajana S, Ruyssen-Witrand A et al (2016) Autoantibodies to human citrullinated fibrinogen and their subfamilies to the α36-50Cit and β60-74Cit fibrin peptides similarly predict radiographic damages: a prospective study in the French ESPOIR cohort of very early arthritides. Rheumatology (United Kingdom) 55(10):1859–1870

23.

Quirke AM, Perry E, Cartwright A, Kelly C, de Soyza A, Eggleton P, Hutchinson D, Venables PJ (2015) Bronchiectasis is a model for chronic bacterial infection inducing autoimmunity in rheumatoid arthritis[J]. Arthritis Rheum 67(9):2335–2342

24.

Kokkonen H, Brink M, Hansson M et al (2015) Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis[J]. Arthritis Res Ther 17:125PubMedPubMedCentral

25.

Fernandes-Cerqueira C, Ossipova E, Gunasekera S et al (2015) Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens. Arthritis Res Ther 17(1)

26.

van Heemst J, Trouw LA, Nogueira L et al (2015) An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting[J]. Arthritis Res Ther 17:276PubMedPubMedCentral

27.

Janssen KM, de Smit MJ, Brouwer E et al (2015) Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study[J]. Arthritis Res Ther 17:174PubMedPubMedCentral

28.

Nogueira L, Cornillet M, Singwe-Ngandeu M, Viatte S, Bas S, Gabay C, Serre G (2014) In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides alpha36-50Cit38,42 and beta60-74Cit60,72,74, like in Caucasians. Clin Immunol 152(1-2):58–64PubMed

29.

Cornillet M, Sebbag M, Verrouil E, Magyar A, Babos F, Ruyssen-Witrand A, Hudecz F, Cantagrel A, Serre G, Nogueira L (2014) The fibrin-derived citrullinated peptide beta60-74Cit(6)(0),(7)(2),(7)(4) bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies. Ann Rheum Dis 73(6):1246–1252PubMed

30.

Fisher BA, Bang SY, Chowdhury M et al (2014) Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease[J]. Ann Rheum Dis 73(4):741–747PubMed

31.

Lundberg K, Bengtsson C, Kharlamova N, Reed E, Jiang X, Kallberg H, Pollak-Dorocic I, Israelsson L, Kessel C, Padyukov L, Holmdahl R, Alfredsson L, Klareskog L (2013) Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 72(5):652–658PubMed

32.

Goules JD, Goules AV, Tzioufas AG (2013) Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis[J]. Clin Exp Immunol 174(1):10–17PubMedPubMedCentral

33.

Brink M, Hansson M, Mathsson L, Jakobsson PJ, Holmdahl R, Hallmans G, Stenlund H, Rönnelid J, Klareskog L, Rantapää-Dahlqvist S (2013) Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis[J]. Arthritis Rheum 65(4):899–910PubMed

34.

Hansson M, Mathsson L, Schlederer T, et al (2012) Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides. Arthritis Res Ther 14(5)

35.

Iobagiu C, Magyar A, Nogueira L, Cornillet M, Sebbag M, Arnaud J, Hudecz F, Serre G (2011) The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted[J]. J Autoimmun 37(4):263–272PubMed

36.

van de Stadt LA, de Koning MH, van de Stadt RJ et al (2011) Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis[J]. Arthritis Rheum 63(11):3226–3233PubMed

37.

Snir O, Widhe M, Hermansson M et al (2010) Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients[J]. Arthritis Rheum 62(1):44–52PubMed

38.

Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, Roudier J, Serre G (2006) Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 36(8):2250–2263PubMed

39.

Sanmarti R, Graell E, Perez ML et al (2009) Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis[J]. Arthritis Res Ther 11(5):R135PubMedPubMedCentral

40.

Avino A, Gomara MJ, Malakoutikhah M et al (2012) Oligonucleotide-peptide conjugates: solid-phase synthesis under acidic conditions and use in ELISA assays. Molecules 17(12):13825–13843PubMedPubMedCentral

41.

Willemze A, van der Woude D, Ghidey W, Levarht EW, Stoeken-Rijsbergen G, Verduyn W, de Vries RR, Houwing-Duistermaat JJ, Huizinga TW, Trouw LA, Toes RE (2011) The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens. Arthritis Rheum 63(7):1823–1832PubMed

42.

James EA, Rieck M, Pieper J et al (2014) Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheum 66(7):1712–1722

43.

Snir O, Rieck M, Gebe JA, Yue BB, Rawlings CA, Nepom G, Malmström V, Buckner JH (2011) Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum 63(10):2873–2883PubMedPubMedCentral

44.

Joshua V, Schobers L, Titcombe PJ et al (2016) Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells. Arthritis Res Ther 18(1):284PubMedPubMedCentral

45.

Haro I, Gomara MJ, Perez ML et al (2011) Antibodies against beta-fibrin synthetic peptides: a study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients. Eur J Med Chem 46(4):1095–1102PubMed

46.

Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, Haj Hensvold A, Eklund A, Sköld CM, Grunewald J, Malmström V, Jakobsson PJ, Rönnelid J, Padyukov L, Zubarev RA, Klareskog L, Catrina AI (2015) Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation[J]. Ann Rheum Dis 74(9):1772–1777PubMed

Titel: Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis
verfasst von: Xue Li
Zhenni Wang
Han Yi
Jun Xie
Naishuo Zhu
Publikationsdatum: 19.12.2019
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 4/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-019-04845-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Detection of rheumatoid arthritis from hand radiographs using a convolutional neural network

Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis

Machine learning–based prediction of radiographic progression in patients with axial spondyloarthritis

Prevalence of musculoskeletal complaints in urban communities in multi-ethnic Suriname: a cross-sectional study with the COPCORD methodology (stage 1, phase 1 and 2)

Evaluating the role of serum sclerostin as an indicator of activity and damage in Egyptian patients with rheumatoid arthritis: university hospital experience